Skip to main content
Equibles
RLMD $4.80 +1.05%
RLMD logo

RLMD · Relmada Therapeutics, Inc.

Track RLMD — free

Use RLMD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RLMD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.80 +0.05 (+1.05%) At close · Aug 14
Market Cap
$512.02M
Shares
106.67M
All earnings calls

Earnings call · FY2024 Q4

Relmada Therapeutics, Inc. Q4 FY2024 Earnings Call

Relmada Therapeutics, Inc. Q4 FY2024 Earnings Call

Concluded Mar 27, 2025
Mar 27, 2025 0 turns
Period
FY2024 Q4
Runtime
—
Sources
2 artifacts
8-K 10-K

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Net income · derived Q4 -$18.66M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 27, 2025 10-K report Filed Mar 27, 2025 Company webcastOpen the original investor-relations page
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)